Cancer-associated thromboembolism in advanced pancreatic cancer: a multi-center prospective observational study

Cancer-associated thromboembolism in advanced pancreatic cancer: a multi-center prospective observational study - Cancer-associated thromboembolism in advanced pancreatic cancer: a multi-center prospective observational study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048619

Enrollment

400

Registered

2022-08-10

Start date

2022-07-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer Cancer-associated thromboembolism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Histologically confirmed unresectable pancreatic cancer

Exclusion criteria

Exclusion criteria: 1. Inappropriate cases judged by investigators 2. Patients with history of medical treatment with pancreatic cancer

Design outcomes

Primary

Measure	Time frame
Incidence of cancer-associated thromboembolism at diagnosis and 3 months post diagnosis in patients with advanced pancreatic cancer	—

Countries

Japan

Contacts

Public ContactLingaku Lee

National Hospital Organization Kyushu Cancer Center Department of Hepato-biliary-pancreatology

frkn505@gmail.com092-541-3231

Outcome results